MEETINGS - Conference on Clarifying Adverse Event Reporting Responsibilities for Medical Devices and Borderline Products (UK) March 2000:
This article was originally published in Clinica
Executive Summary
IIR will hold a conference on Clarifying Adverse Event Reporting Responsibilities for Medical Devices and Borderline Products in London on March 27-28. The meeting will include a keynote address from Joseph Putzeys of the European Commission on implementation of the medical device directives in Europe. There will also be regulatory updates from the UK, France, Germany, Hungary and Norway and practical industry case studies on successfully managing adverse event reporting for medical devices. IIR will also hold a workshop on Overcoming the Practical Challenges of Product Labelling for Medical Devices in London on March 29. For more information contact IIR in UK. Tel: +44 20 7915 5055. Fax: +44 171 915 5001.
You may also be interested in...
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.